Corn Crew Achieved Genetic First, And Then They Were All Let Go

Dorothy Pierce was a good pal to the four people who worked for her. They all called her “Dottie.” But as a supervisor, she also had to be tough enough to motivate her team of biotech researchers when the going got rough—and it did, it got very rough at Richmond, Calif. based Stauffer Chemical. The team’s moniker? The corn transformation group. Its task? To become the first scientists in the world to implant a foreign gene into maize. That was a year ago. Today, the fiv

Written byLaurel Joyce
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

That was a year ago. Today, the five of them—Dottie and her teammates—have been-scattered to the wind, like seed. One would guess, if one had never heard of them, that they must have been unsuccessful as a research team. What one probably wouldn’t guess is that, on the contrary, they achieved a feat that previously had stymied dozens of other agricultural researchers—a feat with commercial ramifications down the road that could earn their employer millions. The truth is, despite their considerable accomplishment, their employer chose to let them go.

For years before Dottie and her crew began their work, geneticists suspected that it might be possible to introduce a foreign gene into a monocot, the class of plants to which corn belongs. If you could do that, they reasoned, you could create plants that are resistant to certain insects or diseases. The problem was: How do you regenerate whole maize ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies